Genetic variants in CYP11B1 influence the susceptibility to coronary heart disease

Xiaoli Huang1, Yimin Cheng2, Na Wang3

  • 1The Department of Cardiovascology, Xi'an Hospital of Traditional Chinese Medicine, No. 69, Fengcheng Eighth Road, Weiyang District, Xi'an, 710021, People's Republic of China.

BMC Medical Genomics
|July 13, 2022
PubMed

Insights

Genetic variations in the CYP11B1 gene, specifically rs4534, rs6410, and rs5283, influence coronary heart disease (CHD) susceptibility. These genetic factors are linked to CHD risk, particularly in relation to age and gender.

Area of Science:

  • Genetics
  • Cardiovascular Disease Research
  • Molecular Biology

Background:

  • Genetic factors are significant contributors to coronary heart disease (CHD) risk.
  • Investigating specific gene mutations, such as those in CYP11B1, is crucial for understanding CHD etiology.
  • The role of CYP11B1 gene variants in the Chinese Han population's CHD risk was previously underexplored.

Purpose of the Study:

  • To investigate the association between CYP11B1 gene mutations and the risk of developing coronary heart disease (CHD).
  • To explore whether specific CYP11B1 variants influence CHD susceptibility in the Chinese Han population.
  • To analyze the impact of these variants on associated conditions like diabetes and hypertension.

Main Methods:

  • Genotyping of six CYP11B1 variants in 509 CHD patients and 509 healthy controls using Agena MassARRAY.
  • Logistic regression analysis to assess correlations between CYP11B1 mutations and CHD risk (OR, 95% CI).
  • Haplotype analysis and multifactor dimensionality reduction (MDR) were employed.

Main Results:

  • Overall analysis showed no significant correlation between CYP11B1 polymorphisms and CHD susceptibility.
  • Stratified analysis revealed significant associations for rs5283, rs6410, and rs4534 with CHD susceptibility, dependent on age and gender (p < 0.05).
  • rs5283 and rs4534 variants were also linked to diabetes/hypertension risk in CHD patients (p < 0.05).
  • A specific haplotype (Crs4736312Ars5017238Crs5301Grs5283Trs6410Crs4534) of CYP11B1 was found to reduce CHD susceptibility (p < 0.05).

Conclusions:

  • Specific CYP11B1 gene variants (rs4534, rs6410, rs5283) are associated with coronary heart disease (CHD) susceptibility.
  • The influence of these variants on CHD risk is modulated by age and gender.
  • These findings contribute to understanding the genetic underpinnings of CHD.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
53
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.7K
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.9K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
213
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
31